Lime Chemicals Limited has announced its unaudited financial results for the quarter ended December 31, 2025, showing a challenging performance with the company reporting a net loss during the period. The Board of Directors approved these results in their meeting held on February 14, 2026.

Financial Performance Overview

The company's financial performance for Q3FY26 showed a significant decline compared to the previous year. The results highlight the operational challenges faced by the calcium carbonate manufacturer during the quarter.

Nine-Month Performance Analysis

The nine-month period ended December 31, 2025, also reflected similar challenges for Lime Chemicals Limited. The company's performance during this extended period showed a reversal from profitability to losses.

Operational Expenses and Cost Structure

The company's expense structure for Q3FY26 totaled Rs 164.58 lakhs compared to Rs 258.22 lakhs in the corresponding quarter of the previous year. Key expense components included purchase of stock in trade at Rs 114.97 lakhs, employee benefits expenses of Rs 17.75 lakhs, and other expenditures amounting to Rs 27.51 lakhs.

Earnings Per Share and Capital Structure

Lime Chemicals Limited reported a basic and diluted earnings per share of Rs (0.14) for Q3FY26, compared to Rs 0.09 in Q3FY25. The company maintained its paid-up equity share capital at Rs 650.47 lakhs with a face value of Rs 10 per share.

Regulatory Compliance and Business Segment

The company operates primarily in manufacturing and dealing of calcium carbonate, which constitutes its single reportable business segment. The financial results were prepared in accordance with Indian Accounting Standards and were reviewed by the Audit Committee before Board approval. The auditors provided an unmodified opinion on the unaudited standalone financial results for the quarter ended December 31, 2025.

Lime Chemicals Limited , a calcium carbonate manufacturer, has reported a net loss for the quarter ended September 30, 2025, according to the company's latest financial results. The Board of Directors approved the unaudited financial results on November 14, 2025, revealing a challenging quarter for the company.

Financial Performance

The company's financial performance for Q2 FY2026 shows a significant downturn compared to the previous quarter. Here's a breakdown of the key financial metrics:

All figures in lakhs

The net loss of ₹15.94 lakhs in Q2 FY2026 marks a significant reversal from the profit of ₹9.91 lakhs recorded in the previous quarter. This represents a negative swing in the company's bottom line.

Operational Performance

The company's revenue from operations declined to ₹185.20 lakhs in the quarter ended September 30, 2025. While the exact figure for the previous quarter's revenue was not provided, the report indicates a decrease in operational income.

Board Meeting and Audit Review

As per the LODR (Listing Obligations and Disclosure Requirements) data:

• The Board of Directors met on November 14, 2025, to consider and approve the unaudited standalone financial results.
• The meeting commenced at 3:45 PM and concluded at 4:20 PM.
• The company's auditors have given an unmodified opinion on the unaudited standalone financial results for the quarter ended September 30, 2025, in compliance with Regulation 33(3)(d) of SEBI Listing Obligations and Disclosure Requirements.

Outlook

The reported net loss and decline in revenue suggest that Lime Chemicals Limited faced operational challenges during the quarter. The company may need to address these issues to improve its financial performance in the coming quarters. Investors and stakeholders will likely be watching closely to see how the company plans to navigate these challenges and return to profitability.